Boehringer Ingelheim International GmbH - Company Profile
Powered by 
All the data and insights you need on Boehringer Ingelheim International GmbH in one report.
$295
- Save hours of research time and resources with
our up-to-date Boehringer Ingelheim International GmbH Strategy Report
- Understand Boehringer Ingelheim International GmbH position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Boehringer Ingelheim International GmbH’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Boehringer Ingelheim International GmbH's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Hubertus von Baumbach
Chairman Executive BoardMr. Hubertus von Baumbach is the Chairman of the company. Prior to this, he served for different roles in the company including member of the board of Managing Directors, Finance from 2012 to 2016; member of the board of Managing Directors, Finance and Animal Health from 2009 to 2012; Vice President, Finance from 2006 to 2008, Head of department Controlling Subsidiaries from 2003 to 2005 and Head-group Controlling CHC from 2002 to 2003.
Michael Schmelmer
Managing Director - Finance & Group Functions Senior ManagementCarinne Knoche-Brouillon
Managing Director - Human Pharma Business Senior ManagementPaola Casarosa
Managing Director - Innovation Unit Senior ManagementGagandeep Singh
Head - Human Pharma India; Managing Director Senior ManagementStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer